Connect with us

Cannabis News

Medical Marijuana ‘Significantly’ Decreases Use Of Opioids By Chronic Pain Patients, New Study Finds

Published

on

A new study shows that marijuana pain can be an effective replacement for the treatment of pain management.

Murdoch University researchers and research centers in Perth Pain Management Center to investigate how people who have been treating people with chronic cancer cancer pain.

Research published in Pain Management on Monday, “Cannabinoid co-prescriptions may be able to reduce the consumption prescribed for the chronic consumption of the pain kingdom.”

To assess the relationship between cannabis and opioids, the researchers followed two patients in a year: they were already in pain in the pain clinic and a Cannabis co-patient and another 53 patients, without Marijuanik, in a clinic.

Basically, median patient was taking about 40 mg opioids a day. After a year, 15 mg Delta-9 thc and 15 mg CBD median dose of 15 mg of CBD, the team “significantly” has reduced 2.7 mg of opioid doses per day. After a year, the opioid was only taking a median 42.3 mg per day.

“The introduction of cannabinoids can create useful reductions of opioid consumer settings in the real world, with additional benefits for disability and insomnia,” Authors of study celurbill. “However, this treatment is only subjected by a sub-group of patients.”

In the Kannabis treatment regiment between the cohort, “the opioid consumption has significantly reduced in 6 to 12 months.”

“Physical activity and sleep also improved. These findings indicate that medicinal cannabis can help patients reduce their opioid activity and improve their physical activity and sleep.

The findings are also consistent with the body of scientific literature, exploring the association between the use of cannabis and opioids.

For example, a study published this year earlier found in drug and alcohol review, among drug users who experience chronic pain every day The use of cannabis was related to greater probability of leaving opioids-Species among men.

Also found a study posted last year Legalization of medical cannabis seemed to significantly reduce the monetary payments of opioids What specializes in pain, authors “declining that in terms of Marijuana doctor, proves that they are available as a replacement.

Last studies also showed the decline of operating operations, legalized by marijuana for adults in jurisdictions. This study found a “Coherent negative relationship between legalization and aggression” has more significant effects on the states that were legalized before the cannon In opium crisis. The authors computed the legalization of recreation marijuana “that 3.5 per person per person is linked to reduction.”

“Our discoveries suggest that you can help recreating access to leisure marijuana to deal with the opioid epidemic,” said the report. “Previous research represents that marijuana (especially doctors) can reduce the prescriptions of opioids, and that we find that overdose can also reduce deaths.”

Another newly published report according to the use of Opioid opioid after the state Marijuana doctor legalization The availability of the legal cannabis was found that both patients with chronic pain reduced the opioid use and helped reduce deaths exceeded by prescription. Overall, the results of the study indicated that “Cannabis has a key role to play in pain management and reduce the use of opioids,” he said.

Another study published in 2023, linked to medical marijuana Minor level of pain and reduced dependence on opioids and other prescription medications. And other February, another published by the American Medical Association (Mother), found chronic pains that received medical marijuana for more than a month viewed important reductions in prescribed opioids.

About Three chronic pain patients reported using cannabis As a treatment option, 2023 mothers published by a report. Most of that group said they used cannabis as another substitute for pain medicines, including opioids.

Other research published that year found that People buy CBD legally significantly reduced opioid prescription feesIt has less recipe for 6.6 and 8.1 percent.

About prescription drugs Medicaid analyzed a 2022 research paper, while he found the legalization of marijuana for adult use “Reduced relevant” prescription drug use To treat multiple conditions.

2023 Report Medical Marijuana Medical Legalization Related Medical Payments reducing doctors-You have other data activities when they use legal access to the prescription drugs that patients use cannabis as an alternative.

Researchers in another study published last year examined Oregon opioid prescription and mortality rates to find it Marijuana retail access by reducing the prescriptions of oversized opioidsAlthough they saw a decline in the decline of death related to opioids.

Last research also indicates that cannabis can be an effective replacement of heels in terms of pain management.

Report published in BMJ magazine, such as marijuana and opioids for chronic painless pain and Canavies found “can be similarly effective and may have fewer interruptions than opioids” Provide potentially comparable relief with a lower chance of harmful effects.

Published special studies found more than half patients with chronic musculoskeletal pain, which was more effective than other analgesic medications cannabis, and 40% reported Reducing the use of other anes in the use of marijuana.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

(Tagstotranslate) highlighted

Continue Reading

Cannabis News

Ora Pharm affirms uninterrupted access to Helius products

Published

on

By

Ora Pharm has confirmed that New Zealand patients, prescribers and pharmacies continue to have uninterrupted access to Helius Therapeutics products following the successful acquisition of the business and its key assets, directly challenging the misinformation being circulated to patients and prescribers by cannabis importer MW Pharma Limited (trading as NUBU).

Industry monitoring was highlighted on Monday, July 20th, when Helius Therapeutics announced that NZ Grow Co. As he inaugurated Growers Day. The event demonstrated the full operational strength, advanced capabilities and integrated supply chain now fully operational under Ora Pharm’s leadership to support the growth of the NZ sector.

At the event, CEO Zoë Reece addressed concerns stemming from a July 9 industry bulletin distributed by NUBU, which stated that “Helius Therapeutics has ceased production and all products are now discontinued.”

© Ora Pharm

Ora Pharm said the statement was incorrect and had the potential to create unnecessary uncertainty in a highly regulated healthcare sector.

“Inaccurate information about the availability of medicines can cause unnecessary worry for patients, prescribers and pharmacies, interfere with treatment decisions and undermine confidence in the New Zealand cannabis industry.”

Ora Pharm completed the business and acquisition of key assets of Helius Therapeutics on June 18, 2026, resuming manufacturing, packaging and nationwide distribution the following day. All Helius brand formulated products and locally grown products remain approved and available for patient supply.

CEO Zoë Reece said the company’s focus is on ensuring continuity of care while strengthening New Zealand’s medicinal cannabis industry.

“The Helius facility gives New Zealand growers direct access to world-class pharmaceutical drying, extraction and manufacturing capabilities. Combined with NZ Grow Co., we are creating a secure and integrated pathway from cultivation to finished products and international markets. Our focus is on clinical continuity, quality assurance and confidence in patients and prescribing physicians every day.”

© Ora Pharm

The integration of the GMP-certified Auckland manufacturing facility with NZ Grow Co.’s cultivation network creates New Zealand’s largest medicinal cannabis supply chain. This unified network insulates domestic patients from volatile international import dependencies while providing independent local growers with a transparent, high-standard route to export markets.

Ora Pharm remains committed to working collaboratively across the sector to support patient access, strengthen confidence in the New Zealand cannabis industry and continue to invest in New Zealand’s pharmaceutical manufacturing capacity.

For more information:
Ora Pharm
(email protected)
www.orapharm.co.nz

Continue Reading

Cannabis News

California Treasurer Announces Hearing On Marijuana Business Banking Access Issues

Published

on

By

California’s state treasurer has announced he will convene a hearing next week to highlight the marijuana industry’s banking access “challenges” and its impact on businesses, workers and communities.

The hearing, organized by Treasurer Fiona Ma (D), comes ten years after her predecessor launched a Cannabis Bank Task Force to look into the issue.

Titled “Continuing the Conversation: Advancing Safe and Legal Banking for California’s Cannabis Industry,” Wednesday’s hearing will feature state and local officials, financial institutions and representatives of marijuana companies. The plan is to “review progress made, discuss remaining obstacles, and consider practical steps California can take to support a safe, transparent and well-regulated legal cannabis market,” Ma’s office said in a press release.

“Nearly a decade after the launch of the Cannabis Banking Working Group, California’s legal cannabis industry continues to face barriers to access to affordable and reliable financial services due to state-federal conflict,” Ma. he said. “This hearing it will help us assess what has changed, identify challenges that remain, and continue the conversation about practical solutions that support public safety, transparency, and responsible business operations.”

Last month, bipartisan members of the US House and Senate reintroduced the legislation protect banks from being penalized for providing financial services to marijuana businesses.

Previous iterations of the banking legislation have been introduced in previous sessions of Congress, and while the House of Representatives has passed versions on several occasions, the reform has never become law.

While some banks serve marijuana businesses, the continued federal illegalization of the plant has made many reluctant to work with the industry.

“Limited access may increase operating costs, complicate routine financial transactions, and require some businesses to handle larger amounts of money, creating additional security and administrative concerns,” Ma’s office said.

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Peat is a lot more sustainable than we think

Published

on

By

Increasing public scrutiny has questioned whether the use of peat is environmentally sustainable. A new review According to Dr. James Altland, research director of the USDA’s Agricultural Research Service, and Dr. Bruce Bugbee of Utah State University, they present a more nuanced picture than much of the current evidence portrays.

“Much of the debate in the popular press suggests that the use of peat in horticulture is unsustainable because it causes global warming and other environmental impacts,” shares James. “We have seen that agriculture is much more sustainable than some parties in the media want us to believe.”

© USDA

Differences between regions matter
The review states that assessments of peatland sustainability should differentiate between regions. While European peatlands have been heavily impacted by centuries of drainage and peat extraction, most Canadian peatlands remain undisturbed, with only a small proportion used for horticulture. According to the authors, this distinction is important when assessing the environmental impact of peat production.

“Currently, Canadian peatlands are sequestering carbon faster than the rate of extraction from container crop production. At current rates of extraction and with appropriate restoration, peatland use in North America is environmentally sustainable.”

The authors note that horticultural peat extraction in Canada accounts for only a small fraction of the total peatland area and that harvested sites are routinely restored after production.

© USDA

Restoration supports long-term recovery
The paper highlights the role of restoration practices, particularly the Moss Layer Transfer Technique (MLTT), in restoring peat-forming ecosystems.

“Restoration techniques, such as the moss layer transfer technique, can turn harvested peatlands into carbon sinks over decades,” he added. The review found that restored peatlands can restore vegetation, biodiversity and carbon sequestration functions over time, while improvements in water storage and hydrological performance are also documented.

© USDA

Alternatives also have environmental impacts
The researchers also looked at published life cycle assessments comparing them to substrates such as peat, korea, wood fiber, perlite and rock wool. “Life cycle assessments show that alternative substrates often have environmental impacts comparable to or greater than peat, especially when considering water use, transport and fertilizer inputs.”

The review concludes that comparisons depend on system limitations and assumptions, and that broad claims that alternatives are inherently more sustainable than peat are not consistently supported by published analyses.

© USDA
Figure A: Global carbon storage in natural systems (Gt, gigatons)
(Hirschler and Osterburg, 2022; Cleary et al, 2005; IPCC, 2023)

Performance remains an important consideration
Beyond sustainability, the paper reviews the functional characteristics that have made peat the reference substrate for container production.

“Soil’s high cation exchange capacity, water retention and stability support optimal plant growth and nutrient uptake,” shares James. The authors point out that these properties contribute to efficient irrigation and fertilizer management, maintaining good root zone conditions.

Although wood fibers, coir, and other materials can reduce peat use in mixes, each introduces its own management considerations, such as nutrient immobilization, water use, or processing requirements.

© USDA
Figure B: Annual carbon flux from human activities and sequestration through natural processes (Gt CO2-eq per year)
(Hirschler and Osterburg, 2022; Cleary et al, 2005; IPCC, 2023)

Managing future demand
As the global demand for soilless growth media is expected to increase significantly in the coming decades, the authors believe that a variety of substrate materials will be required.

“At current rates of extraction and with appropriate restoration, peat use in North America is environmentally sustainable and remains essential for horticulture and urban greening.”

For more information:
US Department of Agriculture
James Altland, Head of Research
Application Technologies Research Unit
(email protected)
www.usda.gov

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media